San Francisco-based appointment booking app Solv Health announced today that it has closed a $16.8 million Series B round of funding. The round was led by Greylock Partners, with participation from Benchmark and Aspect Ventures. In the same announcement, the company also unveiled its new Solv Pay feature, which looks to make remuneration quicker and more convenient for users.
from MobiHealthNews https://ift.tt/2I6ILI2
May 09, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Google, Fitbit collaboration aims to deliver comprehensive health data to care teamsFitbit and Google have entered a partnership focused on better leveraging wearables and cloud-based technologies for digital health, the companies announced this morning. The effort will be largely focused on refining EHRs to… Read More
Surgery coordination app maker Casetabs receives $6 millionSanta Monica, California-based Casetabs, which sells a cloud-based app designed for surgery coordination and communication, has raised $6 million in Series A funding, according to a statement. The investment round was led by … Read More
InTouch Health buys Reach Health, bolstering inpatient, outpatient telehealth presenceIn its second acquisition this year, InTouch Health, which develops enterprise telehealth technology for hospitals and health systems, announced that it has acquired Reach Health, another telemedicine platform. The InTouch-Re… Read More
iBeat's $5.5M funding paves way for summer launch of cardio wearableSan Francisco-based wearable tech company iBeat announced today that it has closed an additional $5.5 million in seed funding, bringing its total round to $10 million. from MobiHealthNews https://ift.tt/2rlWVhE … Read More
Nokia plans to sell digital health division back to Withings cofounderAlmost exactly two years after Nokia acquired French health technology company Withings, it has announced that it is in negations to sell its digital health division back to Withings cofounder Éric Carreel. The deal is expect… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment